PROTAC FKBP Degrader-3

Target: Targets FKBP12 or FKBP12F36V degradation-tag fusion proteins for experimental targeted protein degradation studies.

Binding Site: Binds the FKBP12 ligand pocket and recruited E3 ligase substrate-recognition domain to support productive ternary complex formation.

Mechanism of Action: PROTAC FKBP Degrader-3 is designed for use in PROTAC or targeted protein degradation experiments directed toward FKBP12 or FKBP12F36V degradation-tag fusion proteins. The bifunctional molecule links a target-recognition element to VHL, promoting proximity between the protein of interest and ubiquitination machinery. Productive ternary-complex formation can drive polyubiquitination and proteasome-dependent target depletion, allowing researchers to compare pharmacological inhibition with protein removal. It is suitable for evaluating degradation potency, kinetics, pathway selectivity, and downstream signaling consequences in engineered or disease-relevant cellular models.

• PROTAC-Mediated FKBP Degradation: PROTAC FKBP Degrader-3 is designed to facilitate the targeted degradation of FKBP proteins, enabling researchers to study the functional consequences of FKBP loss. This tool aids in dissecting the role of FKBP in cellular processes, offering insights into its involvement in protein folding and immunoregulation.

• Targeted Protein Degradation in Signal Transduction: By utilizing PROTAC FKBP Degrader-3, scientists can selectively degrade FKBP proteins to explore their roles in signal transduction pathways. This application provides a deeper understanding of how FKBP proteins influence cellular signaling, potentially unveiling novel regulatory mechanisms.

• Investigating FKBP-Related Protein Interactions: PROTAC FKBP Degrader-3 serves as a valuable resource for studying FKBP-related protein interactions. By inducing selective degradation, researchers can map interaction networks and identify potential co-factors or binding partners, advancing knowledge in protein-protein interaction dynamics.

• Exploring FKBP in Disease Models: Employing PROTAC FKBP Degrader-3 allows for targeted degradation of FKBP proteins in various disease models. This approach facilitates the investigation of FKBP's contribution to disease progression and pathogenesis, providing a strategic avenue for researching therapeutic targets.